US Oncology Research

As one of the nation’s largest networks specializing in oncology clinical trials, US Oncology Research offers biopharmaceutical manufacturers a single source for research support and proven research processes. Established in 1993, US Oncology Research has played a pivotal role in the development of 39 of the most recent drugs approved by the FDA.   We offer: Centralized contracting and management of studies for convenient study planning, initiation, and analysis; Comprehensive clinical development research experience, from Phase I to IV; Highly experienced and widely recognized research physicians; Extensive FDA audit experience; A dedicated IT platform and biostatistics and data management services. Learn more about US Oncology Research.